Intranasally. Inhalation of the suspension contained in the vial is carried out by means of a special dispensing nozzle on the vial.
Before the first application of the Momat Rino nasal spray, it is necessary to perform its "calibration". Do not pierce the nasal applicator.
To perform the "calibration", it is necessary to press the metering nozzle 10 times, until splashes appear, indicating that the preparation is ready for use.
Tilt your head and inject the drug into each nostril as recommended by your doctor.
If the medicinal product has not been used for 14 days or longer, you must press the dispensing nozzle 2 times until splashes appear.
Tilt your head and inject the drug into each nostril as recommended by your doctor.
Cleaning the dispensing nozzle.
It is important to clean the dispensing nozzle regularly to avoid improper operation. Remove the cap that protects the nozzle from dust, then gently remove the spray tip. Rinse the spray tip thoroughly and the dust cap in warm water and rinse under the tap.
Do not attempt to open the nasal applicator with a needle or other sharp object, as this will damage the applicator, as a result of which you may take the wrong dose of the drug.
Dry the cap and tip in a warm place. Then attach the spray tip to the vial and screw the dustproof cap back onto the bottle again. When using the nasal spray for the first time after cleaning, a "calibration" must be carried out by pressing the metering nozzle 2 times.
Before each use, vigorously shake the bottle.
Treatment of seasonal or year-round allergic rhinitis
Adults (including the elderly) and adolescents with 12 years of age:
The recommended preventive and therapeutic dose of the drug is 2 inhalations (50 μg each) in each nostril 1 time per day (total daily dose - 200 μg). When the therapeutic effect for maintenance therapy is achieved, it is possible to reduce the dose to 1 inhalation in each nostril 1 time per day (the total daily dose is 100 μg).
If the symptoms can not be reduced by applying the drug at the recommended therapeutic dose, the daily dose can be increased to 4 inhalations in each nostril once a day (total daily dose of 400 μg). After reducing the symptoms of the disease, a dose reduction is recommended.
The onset of the drug is usually observed clinically within 12 hours after the first use of the drug.
Children 2-11 years old:
The recommended therapeutic dose is 1 inhalation (50 μg) in each nostril 1 time per day (total daily dose is 100 μg).
The use of the drug in young children requires the help of adults.
Auxiliary treatment of acute sinusitis or acute chronic sinusitis
Adults (including the elderly) and adolescents with 12 years of age:
The recommended preventive and therapeutic dose of the drug is 2 inhalations (50 μg each) in each nostril 2 times a day (total daily dose - 400 μg). If the symptoms can not be reduced by applying the drug at the recommended therapeutic dose, the daily dose can be increased to 4 inhalations in each nostril 2 times a day (total daily dose 800 mcg). After reducing the symptoms of the disease, a dose reduction is recommended.
Treatment of acute rhinosinusitis without signs of severe bacterial infection:
The recommended dose for adults and adolescents is 2 inhalations (50 μg per each nasal passage) 2 times a day (total daily dose of 400 μg). If symptoms worsen during treatment, specialist consultation is necessary.
Treatment of polyposis of the nose
Adults (including the elderly) of 18 years:
The recommended therapeutic dose of the drug is 2 inhalations (50 μg each) in each nostril 2 times a day (total daily dose - 400 μg).
After reducing the symptoms of the disease, it is recommended to reduce the dose to 2 inhalations (50 μg each) in each nostril 1 time per day (total daily dose - 200 μg).